title: Clinical use of AMD3100 to mobilize CD34+ cells in patients affected by non-Hodgkin's lymphoma or multiple myeloma.
authors.forename: Giovanni
authors.initials: G
authors.lastname: Grignani
authors.forename: Eliana
authors.initials: E
authors.lastname: Perissinotto
authors.forename: Giuliana
authors.initials: G
authors.lastname: Cavalloni
authors.forename: Fabrizio
authors.initials: F
authors.lastname: Carnevale Schianca
authors.forename: Massimo
authors.initials: M
authors.lastname: Aglietta
mesh_terms: D018952:Antigens, CD34 / Q000097:blood / Q000187:drug effects; D001596:Benzylamines; D000080027:Cyclams; D019650:Hematopoietic Stem Cell Mobilization / Q000379:methods*; D006571:Heterocyclic Compounds / Q000627:therapeutic use*; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000276:immunology; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000276:immunology; D019718:Receptors, CXCR4 / Q000037:antagonists & inhibitors*
chemical_list: D018952:Antigens, CD34; D001596:Benzylamines; D000080027:Cyclams; D006571:Heterocyclic Compounds; D019718:Receptors, CXCR4; C088327:plerixafor